The people behind our work.
Founded by medical doctors in 2002, trifermed brings together people committed to helping organisations make better strategic decisions in health innovation.
Our experience has grown across technologies, organisations and health systems. Our work remains grounded in the attention we give to people and the decisions they face.
Our story began with medicine.
Helping improve people’s health was our founding commitment. The ways we contribute have evolved; that commitment continues to guide our work.
Back to Hippocrates means bringing knowledge and judgement into the service of people. For us, it begins with understanding a situation before offering advice.
Understanding before advice.
We listen, explore the context and ask the questions that help clarify what matters.
Clarity in our relationships.
We make assumptions, responsibilities and commitments explicit.
Learning throughout the work.
We revisit our understanding as evidence and perspectives develop.
Meet the team.
Our team combines experience in medicine, company leadership, strategy, project delivery, finance and intelligence systems with the curiosity and capabilities of a new generation.
-

Roy Bateman, MBA
Honorary President & Senior Lead Latin America
LinkedIn -

Prof. Dr. Sergi X. Trilla, MD, MBA
Founder & Chief Executive Officer
LinkedIn -

Marta Fernández, MD
Co-Founder & Chief Operating Officer
LinkedIn -

Amadeo Tusell
Senior Lead MedTech
LinkedIn -

Susana Espinosa
People & Finance Lead
LinkedIn -

Gonzalo Heredia
Project Leader
LinkedIn -

Pol Trilla
Strategic Intelligence Systems & Branding Lead
LinkedIn -

Marta Gómez
Senior Project Manager
LinkedIn -

Pedro Faz
Project Manager
LinkedIn
Our story.
Founded in Barcelona by Prof. Dr. Sergi X. Trilla, MD, MBA and Marta Fernández, trifermed began by connecting European health companies with opportunities in Latin America. The work developed across new technologies, markets and forms of collaboration.
2002
Building bridges
The first work connected European pharmaceutical companies with Latin American markets and supported commercial partnerships within Europe.
2005
A wider conversation
Sergi initiated the Trifermed Social Evening, bringing people together around health, entrepreneurship and society. These gatherings became the roots of EIRA.
2007
Biotechnology and Canada
Work with biotechnology entrepreneurs and Canadian innovators broadened the questions beyond commercial products to technologies still being developed.
2013–2014
International expansion
A London affiliate in 2013 and offices in Montreal and Toronto in 2014 formed part of a wider international presence.
2016–2023
Deepening our US involvement
Activity within the US health innovation ecosystem developed further, with a wholly owned subsidiary established in Cambridge, Massachusetts, in 2023.
Today
Experience informing the next decision
Strategic Framing, Strategic Validation and Strategic Execution bring this experience into one connected system, supported by continuous learning and the development of trifermind.
Experience becomes perspective.
Since 2002, every strategic conversation and collaboration has contributed to the judgement we bring to the next decision.
Experience that goes beyond signing agreements: what follows them matters just as much.
Experience built with clients.
Across domains, health systems, points of intervention and strategic roles.
A selection of organisations we have worked with across our history.
Meet our founder.
Prof. Dr. Sergi X. Trilla, MD, MBA’s experience connects medicine, health industry leadership, teaching, investment and initiatives for Social Impact in Health.
Explore the founder’s story
The EIRA Movement
Initiated by Prof. Dr. Sergi X. Trilla, MD, MBA, EIRA carries forward a journey that began with the Trifermed Social Evening in 2005. It advances Social Impact in Health through Knowledge, Recognition and Community.
Discover the EIRA Movement (external site, opens in a new tab)Get to know us
through a conversation.
Tell us about your organisation and the decision that matters most now.
Let’s talkArrive with complexity. Leave with clarity.































































